Private Management Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-8,381
Closed -$939K 282
2025
Q1
$939K Sell
8,381
-203,002
-96% -$20.9M 0.03% 142
2024
Q4
$19.5M Sell
211,383
-206,514
-49% -$18.6M 0.7% 63
2024
Q3
$35M Sell
417,897
-41,661
-9% -$3.18M 1.23% 18
2024
Q2
$31.5M Buy
459,558
+8,192
+2% +$547K 1.21% 20
2024
Q1
$33.1M Buy
451,366
+326
+0.1% +$25.1K 1.25% 21
2023
Q4
$36.5M Sell
451,040
-1,671
-0.4% -$130K 1.4% 15
2023
Q3
$33.9M Buy
452,711
+26,226
+6% +$2.02M 1.39% 20
2023
Q2
$32.9M Buy
426,485
+6,851
+2% +$546K 1.4% 16
2023
Q1
$34.8M Sell
419,634
-2,684
-0.6% -$222K 1.57% 14
2022
Q4
$36.3M Sell
422,318
-90,387
-18% -$7.16M 1.61% 11
2022
Q3
$31.6M Sell
512,705
-66,871
-12% -$4.22M 1.47% 14
2022
Q2
$35.8M Sell
579,576
-856
-0.1% -$53K 1.57% 16
2022
Q1
$34.5M Sell
580,432
-3,922
-0.7% -$251K 1.4% 22
2021
Q4
$42.4M Buy
584,354
+11,544
+2% +$795K 1.7% 10
2021
Q3
$40M Sell
572,810
-1,486
-0.3% -$104K 1.67% 12
2021
Q2
$39.5M Buy
574,296
+7,057
+1% +$471K 1.73% 10
2021
Q1
$36.7M Buy
567,239
+32,799
+6% +$2.11M 1.68% 17
2020
Q4
$31.1M Buy
534,440
+165,427
+45% +$9.98M 1.59% 15
2020
Q3
$23.3M Buy
369,013
+210,477
+133% +$14.6M 1.52% 25
2020
Q2
$12.2M Buy
+158,536
New +$12.1M 0.85% 50

Other funds holding GILD

Private Management Group's GILD Position: Q2 2025 in Review

Private Management Group sold out of Gilead Sciences (GILD) in Q2 2025, closing a stake of 8,381 shares — an estimated $939K sold.

Private Management Group first reported a position in GILD in Q2 2020 and held it in 20 quarters. The position peaked at $42.4M in Q4 2021. 2,024 funds tracked by Wall St. Rank hold GILD as of Q2 2025.

  • Private Management Group reported no remaining Gilead Sciences position as of Q2 2025 after selling out during the quarter.
  • Private Management Group sold 8,381 Gilead Sciences shares in Q2 2025, an estimated $939K.
  • Private Management Group first reported a position in Gilead Sciences in Q2 2020 and held it in 20 quarters.
  • Private Management Group's Gilead Sciences position peaked at $42.4M in Q4 2021.
  • 2,024 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2025.

Based on Private Management Group's 13F filing for Q2 2025, filed 12 Aug 2025.